Mutations in the genes for three different isotypes of the gap junction channel protein connexin are associated with deafness. This indicates an important role for gap junctions in auditory function and provides an opportunity to explore structure-function relationships in the connexin molecule. We have been examining the distribution of gap junctions and the pattern of connexin expression in the mature inner ear and during development, and the effect of specific mutations on the processing and functionality of the expressed connexin proteins in an in vitro system.

Keywords:
Connexins, Gap junctions, Cochlea, Vestibular system, Supporting cells, Stria vascularis, Endocochlear potential, Hereditary hearing loss
1.
Adams J: Immunolocalisation of connexin 31 in the cochlea. ARO Abstr 2000;442.
2.
Carlisle L, Steel K, Forge A: Endocochlear potential generation is associated with intercellular communication in the stria vascularis: Structual analysis in viable dominant spotting mouse mutant. Cell Tissue Res 1990;262:329–337.
3.
Coutinho P, Messana E, Cotanche DA: Cx43 expression during regeneration in the avian inner ear. ARO Abstr 2001;81.
4.
Denoyelle F, Weil D, Maw MA, et al: Prelingual deafness high prevalence of a 30delG mutation in the connexin26 gene. Hum Mol Genet 1997;6:2173–2177.
5.
Edwards J, Becker D, Forge A: Connexin expression in the inner ear. ARO Abstr 2000;219.
6.
Edwards J, Marziano N, Becker D, Casalotti S, Nevill G, Forge A: Co-localisation of connexin β2 (26) and connexin β6 (30) in cochlear gap junctions. ARO Abstr 2001;533.
7.
Elfgang C, Eckert R, Lichtenberg-Frate H, Butterweck A, Traub O, Klein RA, Hulser DF, Willeke K: Specific permeability and selective formation of gap junction channels in connexin-transfected HeLa cells. J Cell Biol 1995;129:805–817.
8.
Falk MM: Connexin-specific distribution within gap junctions revealed in living cells. J Cell Sci 2000;113:4109–4120.
9.
Forge A: Gap junctions in the stria vascularis and effects of ethacrynic acid. Hear Res 1984;13:189–200.
10.
Forge A: The morphology of the normal and pathological cell membrane and junctional complexes of the cochlea; in Salvi RJ, Henderson D, Hamernik RP, Colletti V (eds): Basic and Applied Aspects of Noise-Induced Hearing Loss. New York, Plenum, 1986, pp 55–67.
11.
Forge A, Becker D, Casalotti S, Edwards J, Evans WH, Lench N, Souter M: Gap junctions and connexin expression in the inner ear; in Gap Junction-Mediated Intercellular Signalling in Health and Disease. Novartis Found Symp 219. London, Wiley, 1999, pp 134–156.
12.
George CH, Martin PE, Evans WH: Rapid determination of gap junction formation using HeLa cells microinjected with cDNAs encoding wild-type and chimeric connexins. Biochem Biophys Res Commun 1998;247:785–789.
13.
Goliger JA, Paul DL: Wounding alters epidermal connexin expression and gap-junction mediated intercellular communication. Mol Biol Cell 1995;6:1491–1501.
14.
Grifa A, Wagner CA, D’Ambrosio L, et al: Mutations in GJB6 cause nonsyndromic autosomal dominant deafness at DFNA3 locus. Nat Genet 1999;23:16–17.
15.
Heller S, Sheane CA, Zarqa J, Hudspeth AJ: Molecular markers for cell types of the inner ear and candidate genes for hearing disorders. Proc Natl Acad Sci USA 1998;95:11400–11405.
16.
Kelsall DP, Dunlop J, Stevens HP, et al: Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature 1997;387:80–83.
17.
Kikuchi T, Kimura RS, Paul DL, Adams JC: Gap junctions in the rat cochlea: Immunohistochemical and ultrastructural analyses. Anat Embryol 1995;191:101–118.
18.
Kikuchi T, Kimura RS, Paul DL, Takasaka T, Adams JC: Gap junction systems in the mammalian cochlea. Brain Res Brain Res Rev 2000;32:163–166.
19.
Kumar NM: Molecular biology of the interactions between connexins; in Gap Junction-Mediated Intercellular Signalling in Health and Disease. Novartis Found Symp 219. London, Wiley, 1999, pp 6–16.
20.
Kumar NM, Gilula NB: The gap junction communication channel. Cell 1996;84:381–388.
21.
Lautermann J, ten Cate WJF, Altenhoff P, Grummer R, Traub O, Frank HG, Jahnke K, Winterhager E: Expression of the gap-junction connexins 26 and 30 in the rat cochlea. Cell Tissue Res 1998;294:415–420.
22.
McDowell B, Davies S, Forge A: The effect of gentamicin-induced hair cell loss on the tight junctions of the reticular lamina. Hear Res 1989;40:221–232.
23.
Martin PE, Coleman L, Casalotti SO, Forge A, Evans WH: Properties of connexin26 gap junctional proteins derived from mutations associated with non-syndromal hereditary deafness. Hum Mol Genet 1999;8:2369–2376.
24.
Santos-Sacchi J: Isolated supporting cells from the organ of Corti: Some whole cell electrical characteristics and estimates of gap junction conductance. Hear Res1991;52:89–98.
25.
Souter M, Forge A: Intercellular junctional maturation in the stria vascularis: Possible association with onset and rise of EP. Hear Res 1998;119:81–95.
26.
Steel KP, Barkway C: Another role for melanocytes: Their importance for normal stria vascularis development in the mammalian inner ear. Development1989;107:453–463.
27.
Wangemann P, Schacht J: Homeostatic mechanisms in the the cochlea; in Dallos P, Popper AN, Fay RR (eds): The Cochlea. New York, Springer, 1996, pp 130–185.
28.
Warchol ME, Corwin JT: Regenerative proliferation in organ cultures of the avian cochlea: Identification of the initial progenitors and determination of the latency of the proliferative response. J Neurosci 1996;16:5466–5477.
29.
Xia A-P, Ikeda K, Katori Y, Oshima T, Kikuchi T, Takasak T: Expression of connexin 31 in the developing mouse cochlea. Neuroreport 2000;11:2449–2453.
30.
Xia J-H, Liu, C-Y, Tang B-S, et al: Mutations in the gene encoding gap junction protein β-3 associated with autosomal dominant hearing impairment. Nat Genet 1998;20:370–373.
31.
Zhao HB, Santos-Sacchi J: Voltage gating of gap junctions in cochlear supporting cell: Evidence for nonhomotypic channels. J Membr Biol 2000;175:17–24.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.